Utah Medical Products UTMD Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 57.9%-0.4pp | 57.1%-1.9pp | 57.1%-1.7pp | 57.3%-1.7pp | 58.4%-0.7pp | |
| Operating margin | 28.8%-3.9pp | 29.6%-3.6pp | 30.8%-2.4pp | 32.5%-0.2pp | 32.8%-0.3pp | |
| Net margin | 28.9%-4.1pp | 29.3%-4.6pp | 30.1%-4.5pp | 32.3%-1.2pp | 33%-0.4pp | |
| EBITDA margin | 36.6%-3.4pp | 37.3%-2.8pp | 38.3%-1.8pp | 40%-1.6pp | 40%-3.8pp | |
| Free cash flow margin | 34.7%0.0pp | 37.2%+1.5pp | 35.9%-2.4pp | 35.5%-3.3pp | 34.7%-6.1pp | |
| Returns | ||||||
| Return on equity | 9.1%-1.4pp | 9.5%-1.8pp | 9.6%-2.7pp | 10.4%-2.3pp | 10.6%-2.7pp | |
| Return on assets | 8.8%-1.3pp | 9.2%-1.5pp | 9.2%-2.5pp | 10%-2.0pp | 10%-2.4pp | |
| Efficiency | ||||||
| Asset turnover | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×-0.1× | |
| Inventory turnover | 1.8×0.0× | 2×+0.2× | 1.9×0.0× | 1.9×-0.1× | 1.8×-0.3× | |
| Liquidity | ||||||
| Current ratio | 28.6×+6.3× | 37.6×+12.0× | 32.1×+2.5× | 41.9×+15.9× | 22.3×+2.7× | |
| Quick ratio | 26.2×+5.9× | 34.6×+11.3× | 29.4×+2.4× | 38.2×+14.5× | 20.3×+2.4× | |
| Cash ratio | 24.9×+5.7× | 33×+10.9× | 28×+2.2× | 36.5×+13.8× | 19.3×+2.1× | |
| Leverage | ||||||
| Debt-to-equity | 0×— | 0×0.0× | 0×0.0× | 0×0.0× | —— | |
| Debt-to-assets | 0×— | 0×0.0× | 0×0.0× | 0×0.0× | —— | |
| Net debt / EBITDA | -6.4×— | -6×-0.9× | -5.7×-0.7× | -5.3×-0.7× | —— | |
| Per Share | ||||||
| Book value per share | $37.79+6.9% | $36.81+9.8% | $36.87+3.3% | $36.21+3.1% | $35.36+0.2% | |
| Valuation | ||||||
| Market capitalization | $219.63M+26.4% | $179.28M-14.0% | $201.86M-16.6% | $180.99M-25.2% | $183.91M-28.5% | |
| Enterprise value | $132.44M+42.5% | $93.81M-25.6% | $117.84M-23.5% | $99.07M-35.2% | —— | |
| Price / earnings | 20.3×+6.4× | 15.9×+0.9× | 17.4×+1.5× | 14.4×-1.1× | 14.2×-1.5× | |
| Price / sales | 5.9×+1.4× | 4.7×-0.4× | 5.2×-0.3× | 4.7×-0.5× | 4.7×-0.6× | |
| Price / book | 1.9×+0.4× | 1.5×-0.3× | 1.7×-0.2× | 1.5×-0.4× | 1.6×-0.4× | |
| EV / EBITDA | 10.5×+4.0× | 6.5×-1.2× | 8×-0.7× | 6.4×-1.5× | —— | |
| EV / sales | 3.9×+1.2× | 2.4×-0.6× | 3.1×-0.4× | 2.6×-0.7× | —— | |
| Free cash flow yield | 5.6%-1.9pp | 8%+1.0pp | 6.9%-0.1pp | 7.6%+0.1pp | 7.4%-0.4pp | |
| Earnings yield | 4.7%-2.2pp | 6.3%-0.4pp | 5.8%-0.5pp | 6.9%+0.5pp | 7%+0.7pp | |
| Dividend yield | 1.7%-0.5pp | 2.2%+0.2pp | 2%+0.2pp | 2.3%+0.5pp | 2.3%+0.6pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Utah Medical Products's profit margins?
- Utah Medical Products (UTMD) runs a 57.9% gross margin and a 28.8% operating margin, with a 28.9% net margin.
- Where do Utah Medical Products's ratios come from?
- Every ratio is computed from Utah Medical Products's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
